About This Fund
TPG Healthcare Partners II is a 2022 vintage buyout fund managed by TPG investing in the healthcare sector. TPG’s global healthcare franchise is led by one of the most experienced teams in private equity. The team invests thematically across strategies: Next-Generation and Value-Centric Care Delivery: Leading care delivery models that are expanding access to underserved populations, reducing healthcare costs through shifts in site of care and introducing patient-centric and risk-bearing solutions. Representative investments include Evolent Health, LifeStance Health, Kelsey-Seybold Clinic, Monogram Health, GoHealth, Zipline, and United Family Healthcare. Investing Behind Innovation: Pharmaceuticals, diagnostics and devices that represent step function innovations that transform patient outcomes, along with the essential enablers of such innovation. Representative investments include Allogene, AskBio, BVI, Novotech, and Precision for Medicine. Technology Enablement: Healthcare technology and related solutions that leverage the power of automation, data & analytics, and interoperability to improve care and patient choice in their own health. Representative investments include Dingdang Health, EnvisionRx, IQVIA, Q-Centrix, and WellSky. Investing for Transformation: Proprietary angles created by the TPG Healthcare team’s robust set of strategic and operational capabilities, including our deep industry knowledge and relationships, experience in building out executive teams and strategic roadmaps, and supporting operational resources and capabilities. Representative investments include Adare, Kindred at Home, Kindred Healthcare, Par Pharmaceutical, and Fenwal.